Impact of insulin-treated diabetes and hemodialysis on long-term clinical outcomes following sirolimus-eluting stent deployment - Insights from a sub-study of the Cypher Stent Japan Post-Marketing Surveillance (Cypher J-PMS) registry

Circulation Journal

Volumn 74, Issue 12, 2010, Pages 2592-2597

  Nakamura, Masato ^a   Yokoi, Hiroyoshi ^b   Hamazaki, Yuji ^c   Watarai, Masato ^d   Kijima, Mikihiro ^e   Mitsudo, Kazuaki ^f  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d ANJO KOSEI HOSPITAL   (Japan)

^e HOSHI GENERAL HOSPITAL   (Japan)

^f KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Angioplasty; Drug eluting stent; Follow up studies

Indexed keywords

INSULIN; RAPAMYCIN;

AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; IMPLANT REGISTRY; JAPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTMARKETING SURVEILLANCE; REVASCULARIZATION; STENT THROMBOSIS; THERAPY EFFECT; TREATMENT DURATION;

AGED; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; JAPAN; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES; RENAL DIALYSIS; SIROLIMUS; THROMBOSIS; TIME FACTORS;

EID: 78649711929     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0179     Document Type: Article

References (21)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-1200.
2. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham study. Circulation 1979; 59: 8-13.
3. Kumbhani D, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL. The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: Insights from randomized trials. Am Heart J 2008; 155: 640-647.
4. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989-997.
5. Cheng CI, Lee FY, Chang JP, Hsueh SK, Hsieh YK, Fang CY, et al. Long-term outcomes of intervention for unprotected left main coronary artery stenosis: Coronary stenting vs coronary artery bypass grafting. Circ J 2009; 73: 705-712.
6. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008; 72: 392-398.
7. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, et al; BASKET-LATE investigators. Late clinical events after clopidogrel discontinuations may limit the benefit of drug-elutings stents: An observational study of drug-eluting vs bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591.
8. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159-168.
9. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
10. Hermiller JB, Raizner A, Cannon L, Kutcher MA, Wong SC, Russell ME, et al; TAXUS-IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: The TAXUS-trail. J Am Coll Cardiol 2005; 45: 1172-1179.
11. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and baremetal stents: A collaborative network meta-analysis. Lancet 2007; 370: 937-948.
12. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolín R, et al; DIABETES Investigators. Randomized comparison of sirolimus-eluting stents versus standard stent for percutaneous coronary revascularization in diabetic patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) trial. Circulation 2005; 112: 2175-2183.
13. Scheen AJ, Warzée F, Legrand VM. Drug-eluting stents: Metaanalysis in diabetic patients. Eur Heart J 2004; 25: 2167-2168.
14. Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, et al. Impact of drug-eluting stents among insulintreated diabetic patients: A report from the NHLBI dynamic registry. JACC Cardiovasc Interv 2008; 1: 139-147.
15. Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, et al. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: Results from a real world multicenter registry. Circulation 2008; 117: 923-930.
16. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, et al. Relationship between diabetes mellitus and longterm survival after coronary bypass and angioplasty. Circulation 1997; 96: 2551-2556.
17. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
18. The BARI 2D Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009; 360: 2503-2515.
19. Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, et al; EVASTENT Investigators. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: The EVASTENT Matched-Cohort Registry. J Am Coll Cardiol 2007; 50: 501-508.
20. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
21. Park DW, Flaherty JD, Davidson CJ, Yun SC, Lee SW, Kim YH, et al. Progrnostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug eluting stent implantation in Asian population. Am J Cardiol 2009; 103: 646-652.